BE using non RLD [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2013-08-05 12:44 (4707 d 21:23 ago) – Posting: # 11198
Views: 6,339

Hi lb,

❝ Done that (submitted an ANDA with a BE on non RLD lower strength) for a highly variable statin and also got approval (along with bio-waiver for all the proportional lower strengths).


Sounds very fishy to me. I think it would render the FDA liable if the originator sues the FDA as a means of brand protection. Was this one of the cases where an originator RLD was not available, perhaps?

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
410 visitors (0 registered, 410 guests [including 31 identified bots]).
Forum time: 10:07 CEST (Europe/Vienna)

Ignorance more frequently begets confidence
than does knowledge.    Charles Darwin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5